Pluri (NASDAQ:PLUR) Issues Earnings Results

Pluri (NASDAQ:PLUR) issued its quarterly earnings results on Tuesday. The company reported ($0.53) earnings per share (EPS) for the quarter, Zacks reports. Pluri had a negative return on equity of 917.18% and a negative net margin of 4,184.28%.

Pluri Price Performance

NASDAQ:PLUR traded up $0.03 during mid-day trading on Tuesday, reaching $4.33. The stock had a trading volume of 4,142 shares, compared to its average volume of 13,152. The stock has a market capitalization of $24.07 million, a P/E ratio of -0.72 and a beta of 1.67. The firm has a 50 day moving average price of $4.53 and a two-hundred day moving average price of $4.99. The company has a debt-to-equity ratio of 4.44, a quick ratio of 5.90 and a current ratio of 5.90. Pluri has a one year low of $4.07 and a one year high of $8.48.

Pluri Company Profile

Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.